Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: a call to action from the cardio-kidney community.
Saved in:
| Title: | Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: a call to action from the cardio-kidney community. |
|---|---|
| Authors: | Pecoits-Filho R; Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA.; Pontificia Universidade Catolica do Parana, Curitiba, Brazil., Wong MMY; Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Moorthy M; International Society of Nephrology, Brussels, Belgium., Banerjee D; Renal and Transplantation Unit, St George's University Hospitals NHS Foundation Trust, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK., Behera S; Division of Nephrology, Southlake Regional Health And Michael G. DeGroote School of Medicine, McMaster University., Calice-Silva V; Research Department, Pro-rim Foundation and School of Medicine, UNIVILLE, Joinville, SC, Brazil., Chothia MY; Division of Nephrology, Department of Medicine, Stellenbosch University, Cape Town, South Africa., Colbert GB; Department of Nephrology, Texas A&M College of Medicine, Dallas, Texas, USA., Gulati M; Barbra Streisand Women's Heart Center, Department of Cardiology, Cedars Sinai Heart Institute, Los Angeles, California, USA., Herzog CA; Cardiology Division, Dept. of Medicine, Hennepin Healthcare/University of Minnesota, Minneapolis, Minnesota, USA., Jouhra F; Cardiology Department, St George's University Hospitals NHS Foundation Trust, Cardiology Clinical Academic Group, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK., Lerma EV; University of Illinois at Chicago/Advocate Christ Medical Center, Oak Lawn, Illinois, USA., Malik C; International Society of Nephrology, Brussels, Belgium., Patel KV; Center for Cardiovascular Prevention, Ascension Texas Cardiovascular, Dell School of Medicine, Austin, Texas, USA., Rakisheva A; Cardiology Department, Scientific Research Institute of Cardiology and Internal Medicine, Almaty, Kazakhstan., Rosano GMC; Centre for Clinical and Basic Research, IRCCS San Raffaele, Rome, Italy., Satish P; Center for Cardiovascular Prevention, Ascension Texas Cardiovascular, Dell School of Medicine, Austin, Texas, USA., Wu HHL; Renal Research, Kolling Institute of Medical Research, Royal North Shore Hospital & The University of Sydney, Sydney, Australia., Wang AY; Department of Renal Medicine, Singapore General Hospital, Duke-National University of Singapore (NUS) Academic Medical Center, Singapore. |
| Source: | ESC heart failure [ESC Heart Fail] 2025 Aug; Vol. 12 (4), pp. 2597-2604. Date of Electronic Publication: 2025 Jun 09. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: John Wiley & Sons Ltd on behalf of the European Society of Cardiology Country of Publication: England NLM ID: 101669191 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2055-5822 (Electronic) Linking ISSN: 20555822 NLM ISO Abbreviation: ESC Heart Fail Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
